|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 262, Issue 2 E191-E196, Copyright © 1992 by American Physiological Society
ARTICLES |
S. Frontoni, L. Ohman, J. R. Haywood, R. A. DeFronzo and L. Rossetti
Department of Medicine, University of Texas Health Science Center, San Antonio.
Insulin resistance has been described in nonobese subjects with essential hypertension. At present it is unknown whether hypertension per se may lead to the onset of insulin resistance. To examine this question we studied in vivo insulin action in two rat models of genetic hypertension. Four groups of conscious rats were studied: Milan hypertensive (MHS), Milan normotensive (MNS), spontaneously hypertensive (SHR), and Wistar-Kyoto (WKY). Mean arterial pressure was increased in SHR vs. WKY in both the fed (184 +/- 5 vs. 126 +/- 6 mmHg; P less than 0.001) and fasting (160 +/- 5 vs. 129 +/- 5; P less than 0.001) states. During high-dose insulin clamps, total body glucose uptake (mg.kg-1.min-1) was similar in MNS (28.7 +/- 1.4) vs. MHS (33.6 +/- 3.0) and in WKY (34.6 +/- 1.8) vs. SHR (35.7 +/- 2.4). During low-dose insulin clamps, suppression of hepatic glucose production (3.5 +/- 0.6 vs. 3.0 +/- 0.5 mg.kg-1.min-1) and stimulation of glycolysis (12.9 +/- 0.8 vs. 14.4 +/- 1.5 mg.kg-1.min-1) were similar in WKY vs. SHR, whereas glucose uptake (24.6 +/- 1.9 vs. 18.3 +/- 1.2 mg.kg-1.min-1; P less than 0.01) and muscle glycogenic rate (10.2 +/- 1.1 vs. 6.5 +/- 1.1 mg.kg-1.min-1; P less than 0.05) were increased in SHR vs. WKY. In conclusion, 1) feeding markedly augments blood pressure in hypertensive but not in normotensive rats, and 2) hepatic and muscle insulin sensitivity are normal or increased in two different rat models of genetic hypertension. These results provide evidence that high blood pressure per se does not invariably lead to the development of insulin resistance.
This article has been cited by other articles:
![]() |
P. Ruggeri, A. Brunori, C. E. Cogo, D. Storace, F. Di Nardo, and R. Burattini Enhanced sympathetic reactivity associates with insulin resistance in the young Zucker rat Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R376 - R382. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gaudreault, M. Santure, A. Nadeau, and H. Bachelard Isradipine and insulin sensitivity in hypertensive rats Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1038 - E1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Friedman, T. Ishizuka, S. Liu, C. J. Farrell, D. Bedol, R. J. Koletsky, H.-L. Kaung, and P. Ernsberger Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E1014 - E1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Sechi, C. A. Griffin, G. Giacchetti, L. Zingaro, C. Catena, E. Bartoli, and M. Schambelan Abnormalities of Insulin Receptors in Spontaneously Hypertensive Rats Hypertension, April 1, 1996; 27(4): 955 - 961. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |